Patents by Inventor David MALLINSON

David MALLINSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220160774
    Abstract: Non-coding RNA, such as miRNA, expression data derived from a cell population is used to infer the propensity of that cell population for a cellular functional effect for a pre-determined purpose, which effect is temporally, procedurally or interventionally separated from the cell population from which the expression data is derived. Thereby, the cellular functional effect of a cell population can be predicted in order to improve decisions and selections to be made relating to the use of cells, e.g. from cells deriving from different donors or batches, for use in bioprocess application or cell therapeutics, in order to enhance productivity, efficiency and/or efficacy.
    Type: Application
    Filed: February 11, 2022
    Publication date: May 26, 2022
    Applicant: SISTEMIC SCOTLAND LTD
    Inventors: David Mallinson, Donald Dunbar, Elaine Gourlay, Daria Olijnyk, James Reid
  • Patent number: 11266687
    Abstract: Non-coding RNA, such as miRNA, expression data derived from a cell population is used to infer the propensity of that cell population for a cellular functional effect for a pre-determined purpose, which effect is temporally, procedurally or interventionally separated from the cell population from which the expression data is derived. Thereby, the cellular functional effect of a cell population can be predicted in order to improve decisions and selections to be made relating to the use of cells, e.g. from cells deriving from different donors or batches, for use in bioprocess application or cell therapeutics, in order to enhance productivity, efficiency and/or efficacy.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: March 8, 2022
    Assignee: SISTEMIC SCOTLAND LTD
    Inventors: David Mallinson, Donald Dunbar, Elaine Gourlay, Daria Olijnyk, James Reid
  • Publication number: 20210139984
    Abstract: A method for determining the presence and level of PSC contaminants in a PSC-derived cell population for use in cell therapy by assaying a sample of the PSC-derived cell population against a panel of non-coding RNAs such as miRNA known to be differentially expressed in PSC contaminants, thereby detecting residual PSC cell contamination at a level of 10 and even 5 or fewer residual contaminating PSC cells in a background of one million cells, such that a PSC-derived cell population or sample may be identified as meeting safety requirements for use in cell therapy.
    Type: Application
    Filed: January 22, 2019
    Publication date: May 13, 2021
    Applicant: SISTEMIC SCOTLAND LTD
    Inventors: David Mallinson, Elaine Gourlay, James Reid, Ditte Andersen
  • Publication number: 20190160101
    Abstract: Non-coding RNA, such as miRNA, expression data derived from a cell population is used to infer the propensity of that cell population for a cellular functional effect for a pre-determined purpose, which effect is temporally, procedurally or interventionally separated from the cell population from which the expression data is derived. Thereby, the cellular functional effect of a cell population can be predicted in order to improve decisions and selections to be made relating to the use of cells, e.g. from cells deriving from different donors or batches, for use in bioprocess application or cell therapeutics, in order to enhance productivity, efficiency and/or efficacy.
    Type: Application
    Filed: May 9, 2017
    Publication date: May 30, 2019
    Inventors: David MALLINSON, Donald DUNBAR, Elaine GOURLAY, Daria OLIJNYK, James REID